Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-009696
Filing Date
2019-08-01
Accepted
2019-08-01 07:43:12
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kaleido-6302019x10q.htm 10-Q 1296539
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 14971
3 EXHIBIT 31.2 exhibit312.htm EX-31.2 14910
4 EXHIBIT 32.1 exhibit321.htm EX-32.1 12847
11 q2pipelinedraft72419.jpg GRAPHIC 109987
  Complete submission text file 0001628280-19-009696.txt   4484665

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kldo-20190630.xml EX-101.INS 577316
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kldo-20190630.xsd EX-101.SCH 30844
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kldo-20190630_cal.xml EX-101.CAL 52932
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kldo-20190630_def.xml EX-101.DEF 146607
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kldo-20190630_lab.xml EX-101.LAB 503283
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kldo-20190630_pre.xml EX-101.PRE 281806
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38822 | Film No.: 19990976
SIC: 2836 Biological Products, (No Diagnostic Substances)